| |
| |
|
| Insider
Information: |
Kong Garheng |
| Relationship: |
Director, 10% Owner |
| City: |
Chapel Hill |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,448,305 |
|
|
Indirect Shares
|
6,795,621 |
|
|
| Direct
Value |
$2,395,617 |
|
|
|
Indirect Value
|
$1,529,015 |
|
|
| Total
Shares |
8,243,926 |
|
|
| Total
Value |
$3,924,631 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 15.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Laboratory Corp of America |
LH |
Director |
2024-02-07 |
11,898 |
2014-12-02 |
0 |
Premium* |
|
|
Melinta Therapeutics, Inc |
MLNT |
Director |
2015-10-26 |
2,830 |
2015-10-26 |
0 |
Premium* |
|
|
Strongbridge Biopharma Plc |
SBBP |
Director |
2021-10-05 |
0 |
2019-05-15 |
0 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
See Remarks |
2020-05-12 |
1,433,577 |
2019-07-29 |
0 |
Premium* |
|
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2019-11-07 |
0 |
2021-12-15 |
6,795,621 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LH |
Laboratory Corp of Americ... |
Director |
• • – |
2024-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
947 |
11,898 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
• • – |
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
742 |
10,951 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
• • – |
2022-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
771 |
10,209 |
0 |
- |
|
| VERO |
Venus Concept Inc |
Director |
– • • |
2021-12-15 |
4 |
B |
$1.25 |
$2,000,000 |
I/I |
1,600,000 |
6,795,621 |
2.25 |
% |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2021-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(63,993) |
0 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2021-10-01 |
4 |
D |
$2.06 |
$36,592 |
D/D |
(17,763) |
63,993 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
81,756 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2021-05-14 |
4 |
D |
$2.35 |
$45,120 |
D/D |
(19,200) |
41,756 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
• • – |
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
986 |
9,438 |
0 |
- |
|
| VERO |
Venus Concept Inc |
Director |
– • • |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,200,000 |
5,195,621 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2020-05-15 |
4 |
D |
$2.86 |
$54,466 |
D/D |
(19,044) |
60,956 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
80,000 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2020-05-12 |
4 |
AS |
$34.50 |
$8,624,600 |
D/D |
(250,000) |
1,433,577 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2020-02-19 |
4 |
AS |
$32.03 |
$800,750 |
D/D |
(25,000) |
1,683,577 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2020-02-13 |
4 |
AS |
$32.01 |
$800,250 |
D/D |
(25,000) |
1,708,577 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
• • – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,227 |
8,452 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2020-02-06 |
4 |
AS |
$31.03 |
$775,750 |
D/D |
(25,000) |
1,733,577 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2020-02-03 |
4 |
AS |
$31.06 |
$776,525 |
D/D |
(25,000) |
1,758,577 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2020-01-31 |
4 |
AS |
$30.02 |
$750,388 |
D/D |
(25,000) |
1,783,577 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2020-01-28 |
4 |
AS |
$30.02 |
$750,493 |
D/D |
(25,000) |
1,808,577 |
0 |
- |
|
| VERO |
Venus Concept Inc |
Director |
– • • |
2019-11-07 |
4 |
A |
$0.00 |
$4,999,999 |
I/I |
3,995,621 |
3,995,621 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2019-07-29 |
4 |
B |
$16.00 |
$1,000,000 |
D/D |
62,500 |
1,833,577 |
2.45 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2019-07-29 |
4 |
S |
$16.00 |
$144 |
D/D |
(9) |
1,771,077 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2019-07-29 |
4 |
OE |
$0.02 |
$231 |
D/D |
11,572 |
1,771,086 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
10% Owner |
– – • |
2019-07-29 |
4 |
A |
$0.00 |
$1,068,198 |
D/D |
1,759,514 |
1,759,514 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
